has no effect on the insulin requirements of diabetics, nor does it affect the diabetic control
of patients taking glibenclamide (glyburide
reduces the clearance of tolbutamide
, but as yet there appear to be no case reports of this interaction. Sulfinpyrazone
modestly increased the AUC of nateglinide
, but this is unlikely to be clinically relevant.
No action needed.